Beijing Tiantan Biological Products Corp Ltd Cash Flow Reinvestment Rate
Beijing Tiantan Biological Products Corp Ltd cash flow reinvestment rate. Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥125.07 Million (capex CN¥125.07 Million ) from operating cash flow of CN¥318.80 Million. See financial agility of Beijing Tiantan Biological Products Corp to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Cash flow reinvestment rate of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Historical reinvestment intensity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Explore 600161 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Beijing Tiantan Biological Products Corp Ltd Cash Flow Reinvestment Rate by Year (1998–2024)
Beijing Tiantan Biological Products Corp Ltd cash flow reinvestment rate by year from 1998 to 2024. Year-by-year capital reinvestment analysis for Beijing Tiantan Biological Products Corp Ltd. For the full cash flow conversion analysis, see how efficiently does Beijing Tiantan Biological Products Corp generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥1.11 Billion | CN¥819.78 Million | CN¥1.07 Billion | ▲ +29.8% |
| 2023 | 1.05x | CN¥2.51 Billion | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -63.4% |
| 2022 | 2.86x | CN¥3.22 Billion | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +29.9% |
| 2021 | 2.21x | CN¥2.16 Billion | CN¥980.35 Million | CN¥1.13 Billion | ▲ +149.7% |
| 2020 | 0.88x | CN¥619.92 Million | CN¥702.11 Million | CN¥608.91 Million | ▲ +2.9% |
| 2019 | 0.86x | CN¥551.23 Million | CN¥642.47 Million | CN¥526.23 Million | ▲ +79.6% |
| 2018 | 0.48x | CN¥323.90 Million | CN¥677.92 Million | CN¥293.90 Million | ▼ -39.6% |
| 2017 | 0.79x | CN¥172.87 Million | CN¥218.39 Million | CN¥144.87 Million | ▲ +42.8% |
| 2016 | 0.55x | CN¥237.39 Million | CN¥428.37 Million | CN¥209.39 Million | ▼ -20.2% |
| 2015 | 0.69x | CN¥328.57 Million | CN¥473.26 Million | CN¥300.57 Million | ▼ -28.5% |
| 2014 | 0.97x | CN¥464.16 Million | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥548.37 Million | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥557.87 Million | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥718.67 Million | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥297.54 Million | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥191.17 Million | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥150.31 Million | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥66.40 Million | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥71.50 Million | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥39.78 Million | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥85.89 Million | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥90.02 Million | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥34.83 Million | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥49.09 Million | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥44.04 Million | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥43.34 Million | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥57.61 Million | CN¥23.71 Million | CN¥57.61 Million | — |